Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 170.90
-1.89 (-1.09%)
Jun 1, 2026, 3:29 PM IST
Piramal Pharma Revenue
In the fiscal year ending March 31, 2026, Piramal Pharma had annual revenue of 88.69B INR, down -3.08%. Piramal Pharma had revenue of 27.52B in the quarter ending March 31, 2026, a decrease of -0.08%.
Revenue
88.69B
Revenue Growth
-3.08%
P/S Ratio
2.59
Revenue / Employee
16.20M
Employees
5,476
Market Cap
229.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 88.69B | -2.82B | -3.08% |
| Mar 31, 2025 | 91.51B | 9.80B | 11.99% |
| Mar 31, 2024 | 81.71B | 10.90B | 15.39% |
| Mar 31, 2023 | 70.82B | 3.47B | 5.16% |
| Mar 31, 2022 | 67.34B | 8.47B | 14.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ipca Laboratories | 98.21B |
| Emcure Pharmaceuticals | 92.04B |
| Alembic Pharmaceuticals | 73.45B |
| Gland Pharma | 64.31B |
| Ajanta Pharma | 54.53B |
| Strides Pharma Science | 48.59B |
| NATCO Pharma | 43.76B |
| Wockhardt | 33.73B |
Piramal Pharma News
- 4 weeks ago - Piramal Pharma Transcript: Q4 25/26 - Transcripts
- 4 weeks ago - Piramal Pharma Quarterly report: Q4 2026 - Filings
- 4 weeks ago - Piramal Pharma Slides: Q4 2026 - Filings
- 4 months ago - Piramal Pharma Transcript: Q3 25/26 - Transcripts
- 4 months ago - Piramal Pharma Quarterly report: Q3 2026 - Filings
- 4 months ago - Piramal Pharma Slides: Q3 2026 - Filings
- 7 months ago - Piramal Pharma Transcript: Q2 25/26 - Transcripts
- 7 months ago - Piramal Pharma Quarterly report: Q2 2026 - Filings